Literature DB >> 18611929

Merits of the PMiT (papillary microtumor) terminology in the definition of a subset of incidental papillary microcarcinomas of the thyroid.

Sofia Asioli1, Chiara Odasso, Luigia Macrì, Nicola Palestini, Gianni Bussolati.   

Abstract

An exponential increase in the detection of papillary thyroid microcarcinomas (PTMCs) has been observed in recent times, possibly because of recent improvements in the management of thyroid lesions and extensive histological examination. However, no definitive treatment guideline has been developed for PTMC, resulting in patients undergoing overtreatment. In 2003, the term papillary microtumor of the thyroid (PMiT) was proposed for small (< or =1 cm) intrathyroidal tumors with excellent prognostic prospects along with strict definition criteria. Since then, the term PMiT has been adopted by clinicians and surgeons. In this article, the authors report a series of 50 consecutive cases of PMiT collected and treated at the University Hospital of Turin, Italy. From the authors' experience, this terminology, which demarks a subset of PTMC, should be widely adopted as it is biologically sound, well accepted by both clinicians and patients, decreases the danger of overtreatment, minimizes the psychological anxiety engendered by a diagnosis of carcinoma, and maintains the patient's eligibility for health insurance.

Entities:  

Mesh:

Year:  2008        PMID: 18611929     DOI: 10.1177/1066896908321181

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

Review 1.  Thyroid Growth and Cancer.

Authors:  Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2015-08-26

2.  Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.

Authors:  Gundula Rendl; Margarida Rodrigues; Gregor Schweighofer-Zwink; Josef Hutter; Anton Hittmair; Barbara Zellinger; Cornelia Hauser-Kronberger; Christian Pirich
Journal:  Wien Klin Wochenschr       Date:  2017-05-10       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.